Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time
- PMID: 24139235
- DOI: 10.1016/j.eururo.2013.09.050
Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time
Abstract
Background: Standard survival statistics do not take into consideration the changes in the weight of individual variables at subsequent times after the diagnosis and initial treatment of bladder cancer.
Objective: To assess the changes in 5-yr conditional survival (CS) rates after radical cystectomy for bladder cancer and to determine how well-established prognostic factors evolve over time.
Design, setting, and participants: We analyzed data from 8141 patients treated with radical cystectomy at 15 international academic centers between 1979 and 2012.
Interventions: Radical cystectomy and pelvic lymph node dissection.
Outcome measurements and statistical analysis: Conditional cancer-specific survival (CSS) and overall survival (OS) estimates were calculated using the Kaplan-Meier method. The multivariable Cox regression model was used to calculate proportional hazard ratios for the prediction of mortality after stratification by clinical characteristics (age, perioperative chemotherapy status) and pathologic characteristics (pT stage, grade, lymphovascular invasion, pN stage, number of nodes removed, margin status). The median follow-up was 32 mo.
Results and limitations: The 5-yr CSS and OS rates were 67.7% and 57.5%, respectively. Given a 1-, 2-, 3-, 5- and 10-yr survivorship, the 5-yr conditional OS rates improved by +5.6 (60.7%), +8.4 (65.8%), +7.6 (70.8%), +3.0 (72.9%), and +1.9% (74.3%), respectively. The 5-yr conditional CSS rates improved by +5.6 (71.5%), +9.8 (78.5%), +7.9 (84.7%), +7.2 (90.8%), and 5.6% (95.9%), respectively. The 5- and 10-yr CS improvement was primarily noted among surviving patients with advanced stage disease. The impact of pathologic parameters on CS estimates decreased over time for both CSS and OS. Findings were confirmed on multivariable analyses. The main limitation was the retrospective design.
Conclusions: CS analysis demonstrates that the patient risk profile changes over time. The risk of mortality decreases with increasing survivorship. The CS rates improve mainly in the case of advanced stage disease. The impact of prognostic pathologic features decreases over time and can disappear for long-term CS.
Keywords: Bladder cancer; Conditional survival; Outcome; Radical cystectomy.
Copyright © 2013. Published by Elsevier B.V.
Comment in
-
Re: Conditional Survival after Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time.J Urol. 2016 Mar;195(3):610-1. doi: 10.1016/j.juro.2015.12.003. Epub 2015 Dec 10. J Urol. 2016. PMID: 26887704 No abstract available.
Similar articles
-
Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.Eur Urol. 2014 Nov;66(5):920-8. doi: 10.1016/j.eururo.2014.03.015. Epub 2014 Apr 16. Eur Urol. 2014. PMID: 24768522
-
Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.Eur Urol. 2013 Nov;64(5):837-45. doi: 10.1016/j.eururo.2012.07.026. Epub 2012 Jul 20. Eur Urol. 2013. PMID: 22877503
-
Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.Eur Urol. 2013 Sep;64(3):465-71. doi: 10.1016/j.eururo.2013.03.043. Epub 2013 Apr 3. Eur Urol. 2013. PMID: 23571005
-
Malignant urachal neoplasms: A population-based study and systematic review of literature.Urol Oncol. 2017 Jan;35(1):33.e11-33.e19. doi: 10.1016/j.urolonc.2016.07.021. Epub 2016 Sep 1. Urol Oncol. 2017. PMID: 27592530 Review.
-
Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis.Int J Surg. 2018 Apr;52:214-220. doi: 10.1016/j.ijsu.2018.02.049. Epub 2018 Feb 27. Int J Surg. 2018. PMID: 29496649 Review.
Cited by
-
Benefit of Adjuvant Chemotherapy After Radical Cystectomy for Treatment of Urothelial Carcinoma of the Bladder in the Elderly -An International Multicenter Study.Bladder Cancer. 2021 May 25;7(2):173-185. doi: 10.3233/BLC-200391. eCollection 2021. Bladder Cancer. 2021. PMID: 38994534 Free PMC article.
-
The impact of preoperative nutritional status on post-surgical complication and mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review of the literature.World J Urol. 2021 Apr;39(4):1045-1081. doi: 10.1007/s00345-020-03291-z. Epub 2020 Jun 9. World J Urol. 2021. PMID: 32519225
-
Conditional survival of metastatic clear cell renal cell carcinoma: How prognosis evolves after cytoreductive surgery of primary tumor.Cancer Med. 2021 Nov;10(21):7492-7502. doi: 10.1002/cam4.4270. Epub 2021 Sep 12. Cancer Med. 2021. PMID: 34514731 Free PMC article.
-
The Role of Anesthetic Drugs and Statins in Prostate Cancer Recurrence: Starting at the Actual Knowledge and Walking through a New Paradigm.Cancers (Basel). 2023 Jun 5;15(11):3059. doi: 10.3390/cancers15113059. Cancers (Basel). 2023. PMID: 37297021 Free PMC article. Review.
-
LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway.Oncol Lett. 2017 Nov;14(5):5556-5562. doi: 10.3892/ol.2017.6886. Epub 2017 Sep 4. Oncol Lett. 2017. PMID: 29113184 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical